An ocular manifestation of a systemic disease is an ocular condition that directly or indirectly results from a pathologic process from another part of the body. Ocular manifestations can occur in various systemic diseases in pediatrics. However, ocular manifestations are difficult to recognize especially in pediatric diseases because most clinicians ignore ocular involvement of systemic diseases. Ocular manifestations can be the first findings of systemic disease in some pediatric disease, and numerous ocular manifestations can be associated with amblyopia, which is a disorder of sight. Therefore we must be able to recognize the ocular manifestations for diagnosis and management of pediatric systemic diseases.
INTRODUCTION
tion occurs in about 10%. CT Scanning or ultrasound may show enlarged extraocular muscles, but significantly limitation of ocular movement is rare and visually threatening problems have not been reported [3] . The condition generally shows a good prognosis for spontaneous resolution, usually without recurrence or need for major intervention such as intravenous steroids or decompression of orbit [4] .
HYPOPARATHYROIDISM
Hypocalcemia is a common metabolic problem in newborns, and is usual in neonates which presents within 72 hours, especially in prematurity, in neonates with asphyxiation, and in infants of diabetic mothers. After the 2nd-3rd day and during the first week, the degree of serum calcium is determined by the type of feeding (late neonatal hypocalcemia) [5] . In these neonates with hypocalcemia, the function made by the parathyroid glands remains to be verified.
There is a spectrum of deficient parathyroid with clinical signs varying from asymptomatic to those of longstanding status [6] .
Mild insufficiency may be detected only by adequate research results. Cataracts in infants with complete disorders are a direct result of hypoparathyroidism [7] ; other autoimmune eye disorders such as keratitis and conjunctivitis can also appear [8] .
DIABETES MELLITUS
Pediatric diabetes mellitus was mostly considered as the type 1 insulin-dependent form, until recently [9] . With increasing weight gain in the pediatric population however, type 2 diabetes and insulin resistance now stands as an emerging epidemic in children and adolescents, resulting 8-45% of all juvenile diabetes [10] . Initial screening of pediatric diabetic patients by eye doctors between 3-5 years following diagnosis remains critical.
Opacities of lens occur infrequently in children with diabetes mellitus. When they do develop, they usually appear in the teenage years. They frequently start as cortical opacities but may rapidly progress to total lens opacities. Diabetic retinopathy, while rare in children, is strongly correlated with duration of diabetes and overall control of glucose. The prevalence of diabetic retinopathy rises consistently following puberty, with a 4.8 times greater risk of postpubescent adolescents developing diabetic retinopathy relative to pubescent or pre-pubescent children with the same duration of diabetes [11] .
PORPHYRIA
Porphyrias are a group of rare diseases in which chemical substances called porphyrins accumulate resulting from alteration of the enzymes that transform the various porphyrins into others [12] . These enzymes are most abundant in the blood, bone marrow, and liver. Erythropoietic porphyrias usually exist at birth or early infancy with cutaneous photosensitivity, or in the situation of congenital erythropoietic porphyria (CEP), even in non-immune hydrops fetalis in utero. Erythropoietic protoporphyria (EPP) is the most interesting pathophysiology (or phenomenon) to pediatricians.
Phototoxic changes of the lids, the conjunctiva and the sclera show the fundamental pathological mechanism leading to clinical manifestations in CEP. Contracture of the lids may result in incomplete closure of eyelids with unhealed keratitis and severe aggravation of light induced change to conjunctiva and sclera [13] .
CYSTINOSIS
Cystinosis is a rare disorder caused by a failure in the metabolism of cysteine that results in deposit of cystine crystals in the major parts of the body, mainly the kidney, liver, eye, and brain [14] . Ocular manifestations include photophobia, retinal disorder, and loss of vision.
MUCOPOLYSACCHARIDOSIS
Mucopolysaccharidoses are genetic, progressive disorders caused by mutations of chromosomes coding for lysosomal enzymes needed to degrade glycosaminoglycans (acid mucopolysaccharides).
Glycosaminoglycans (GAGs) are long-chain complex carbohydrates comprised of uronic acids, amino sugars, and neutral sugars [15] .
The corneas take on a "ground glass" shape that, in some instances is better seen with light illumination than on slit-lamp mi- 
WILSON DISEASE
Wilson disease usually shows either with liver disorder at 5-20 years of age or with neurological symptoms, typically between 20-40 years, but sometimes during in childhood [16] . Liver manifestations include chronic active hepatitis, cirrhosis and fulminant hepatic failure. Deposition of copper in peripheral corneal Descemet' s membrane was detected as golden brown pigmentations: the Kayser-Fleischer ring [17] .
JUVENILE IDIOPATHIC ARTHRITIS
Juvenile rheumatoid arthritis, also known as juvenile idiopathic arthritis, is the most common type of arthritis in children under the age of 17 [18] . JIA is comprised of a heterogeneous group of several disease subtypes. The cause and pathology of JIA are mostly unknown, and the hereditary portion is difficult, making complete differentiation among various subtypes complex. and 80% present of ANA [19] .
SYSTEMIC LUPUS ERYTHEMATOSUS
Systemic lupus erythematosus (SLE), also known simply as lupus, is an autoimmune disorder characterized by multiorgan inflammation and the existence of various autoantibodies [20] . SLE can appear in pediatrics and adolescents, especially affecting women of reproductive age. Although most body parts may be influenced, SLE is a chronic inflammatory connective tissue disorder that can involve joints, kidneys, skin, mucous membranes, and blood vessels , and the central nervous system [21] .
The vasculopathy associates small arteries, arterioles, and capillaries, resulting in fibrinoid necrosis. Hypersensitivity vasculitis was detected in 28% of cases. Thrombosis is more likely found in the existence of anticardiolipin autoantibodies, and these may also occur as a separate phenomenon in the antiphospholipid syndrome, or precede the occurrence of SLE for several years. CNS disease may be involved by diffuse vasculopathy and localized thrombosis exacerbated by the presence of anticardiolipin autoantibodies.
Five percent of pediatrics with SLE has eye involvement. The most frequent eye involvement is dry eye: however, chronic inflammation of cornea and conjunctiva is uncommon. Lupus retinopathy is a mark of severe diffuse vasculopathy and may be involved by simultaneous hypertensive changes. Scleritis, episecleritis, and keratitis are rare and may indicate uncontrolled systemic disease.
MARFAN SYNDROME
Marfan syndrome (MFS) is a genetic, systemic, connective tissue disorder from mutations in the FBN1 or fibrillin gene on chromosome 15 [22] . It primarily involves the skeletal, ocular, and cardiovascular systems. 
WEILL-MARCHESANI SYNDROME
Weill-Marchesani syndrome is an uncommon systemic connective tissue disease. Affected patients exhibit microspherophakia, ectopia lentis, lenticular myopia, and glaucoma in conjunction with short stature, brachydactyly, and joint stiffness [24] . As well as FBN1 mutations (type 2), the syndrome may be originated from homozygous or compound heterozygous mutations in ADAMTS10 (type 1) or homozygous mutations in LTBP2 (type 3). 
CONCLUSIONS
This comprehensive review paper describes a short but complete guide to ocular involvement of various pediatric diseases. An ocular manifestation of a pediatric systemic disease can be its first visible presentation, and the eye can provide clues for diagnosis of systemic diseases. For the proper diagnosis and management of pediatric systemic diseases, we need to pay attention to the involved ocular manifestations.
